{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:26:01Z","timestamp":1791127561287,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.mib.2012.05.009","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T04:00:39Z","timestamp":1339473639000},"page":"317-324","source":"Crossref","is-referenced-by-count":33,"title":["Vaccines against botulism"],"prefix":"10.1016","volume":"15","author":[{"given":"Andrew P-A","family":"Karalewitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2012.05.009_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1504\/TBJ.2008.018951","article-title":"How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action","volume":"1","author":"Poulain","year":"2008","journal-title":"Botulinum J"},{"key":"10.1016\/j.mib.2012.05.009_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1615\/CritRevImmunol.v30.i2.50","article-title":"Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition","volume":"30","author":"Aoki","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.mib.2012.05.009_bib0015","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(96)00094-1","article-title":"Mapping of protective and cross-reactive domains of the type a neurotoxin of clostridium botulinum","volume":"14","author":"Dertzbaugh","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.009_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","article-title":"The action of botulinum toxin on the neuro-muscular junction","volume":"109","author":"Burgen","year":"1949","journal-title":"J Physiol"},{"key":"10.1016\/j.mib.2012.05.009_bib0025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0022-3565(25)05861-6","article-title":"On the mechanism of paralysis resulting from toxin of clostridium botulinum","volume":"89","author":"Torda","year":"1947","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mib.2012.05.009_bib0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.neuro.26.041002.131412","article-title":"The synaptic vesicle cycle","volume":"27","author":"Sudhof","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.mib.2012.05.009_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0006-291X(72)90350-6","article-title":"A common subunit structure in clostridium botulinum type a, b and e toxins","volume":"48","author":"DasGupta","year":"1972","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mib.2012.05.009_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mib.2012.05.009_bib0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type a and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.mib.2012.05.009_bib0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/78005","article-title":"Structural analysis of the catalytic and binding sites of clostridium botulinum neurotoxin b","volume":"7","author":"Swaminathan","year":"2000","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.mib.2012.05.009_bib0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.mib.2012.05.009_bib0060","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1073\/pnas.0700046104","article-title":"Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes","volume":"104","author":"Fischer","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2012.05.009_bib0065","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1073\/pnas.0812839106","article-title":"Bimodal modulation of the botulinum neurotoxin protein-conducting channel","volume":"106","author":"Fischer","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2012.05.009_bib0070","series-title":"Essential of Glycobiology","author":"Varki","year":"2009"},{"key":"10.1016\/j.mib.2012.05.009_bib0075","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1111\/j.1742-4658.2011.08196.x","article-title":"Exchange of the h(cc) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin","volume":"278","author":"Rummel","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.mib.2012.05.009_bib0080","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1471-4159.2009.06093.x","article-title":"Cell entry strategy of clostridial neurotoxins","volume":"109","author":"Thomas","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.mib.2012.05.009_bib0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nsmb0107-9","article-title":"Botulinum neurotoxin b-host receptor recognition: it takes two receptors to tango","volume":"14","author":"Baldwin","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.mib.2012.05.009_bib0090","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1016\/S0021-9258(17)34087-5","article-title":"Identification of protein receptor for clostridium botulinum type b neurotoxin in rat brain synaptosomes","volume":"269","author":"Nishiki","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2012.05.009_bib0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"Sv2 is the protein receptor for botulinum neurotoxin a","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mib.2012.05.009_bib0100","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1083\/jcb.200305098","article-title":"Synaptotagmins i and ii mediate entry of botulinum neurotoxin b into cells","volume":"162","author":"Dong","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.mib.2012.05.009_bib0105","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.E08-07-0765","article-title":"Glycosylated sv2a and sv2b mediate the entry of botulinum neurotoxin e into neurons","volume":"19","author":"Dong","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.mib.2012.05.009_bib0110","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1021\/bi9002138","article-title":"Glycosylated sv2 and gangliosides as dual receptors for botulinum neurotoxin serotype f","volume":"48","author":"Fu","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.mib.2012.05.009_bib0115","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1471-4159.2009.06298.x","article-title":"Botulinum neurotoxins c, e and f bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin f utilising the three isoforms of sv2 as second receptor","volume":"110","author":"Rummel","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.mib.2012.05.009_bib0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nsb879","article-title":"Translocation of botulinum neurotoxin light chain protease through the heavy chain channel","volume":"10","author":"Koriazova","year":"2003","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.mib.2012.05.009_bib0125","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1074\/jbc.M111.224493","article-title":"Association of botulinum neurotoxin serotype a light chain with plasma membrane-bound snap-25","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2012.05.009_bib0130","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and botulinum-b neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.mib.2012.05.009_bib0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/B:GLYC.0000046271.64647.fd","article-title":"Glycosphingolipids\u2014sweets for botulinum neurotoxin","volume":"21","author":"Yowler","year":"2004","journal-title":"Glycoconj J"},{"key":"10.1016\/j.mib.2012.05.009_bib0140","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1074\/jbc.275.12.8889","article-title":"The structures of the hc fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding","volume":"275","author":"Emsley","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2012.05.009_bib0145","doi-asserted-by":"crossref","first-page":"30380","DOI":"10.1074\/jbc.272.48.30380","article-title":"Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand","volume":"272","author":"Shapiro","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2012.05.009_bib0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","article-title":"The hcc-domain of botulinum neurotoxins a and b exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction","volume":"51","author":"Rummel","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.mib.2012.05.009_bib0155","doi-asserted-by":"crossref","first-page":"e1000129","DOI":"10.1371\/journal.ppat.1000129","article-title":"Crystal structure of botulinum neurotoxin type a in complex with the cell surface co-receptor gt1b \u201cinsight into the toxin\u201d neuron interaction","volume":"4","author":"Stenmark","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2012.05.009_bib0160","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature05411","article-title":"Structural basis of cell surface receptor recognition by botulinum neurotoxin b","volume":"444","author":"Chai","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.mib.2012.05.009_bib0165","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature05387","article-title":"Botulinum neurotoxin b recognizes its protein receptor with high affinity and specificity","volume":"444","author":"Jin","year":"2006","journal-title":"Nature"},{"issue":"Suppl. 4","key":"10.1016\/j.mib.2012.05.009_bib0170","doi-asserted-by":"crossref","first-page":"D33","DOI":"10.1016\/j.vaccine.2009.08.059","article-title":"Botulism and vaccines for its prevention","volume":"27","author":"Smith","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.009_bib0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4049\/jimmunol.16.4.391","article-title":"The effect of formalin on botulinum toxins a, b and c","volume":"16","author":"Graham","year":"1929","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2012.05.009_bib0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.55.3.245","article-title":"Studies on botulinum toxoid, types a and b","volume":"55","author":"Nigg","year":"1947","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2012.05.009_bib0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.55.4.309","article-title":"Studies on botulinum toxoids, types A and B; immunization of man","volume":"55","author":"Reames","year":"1947","journal-title":"J Immunology"},{"key":"10.1016\/j.mib.2012.05.009_bib0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JB.73.1.42-47.1957","article-title":"Studies on immunity to toxins of clostridium botulinum i. A","volume":"73","author":"Duff","year":"1957","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mib.2012.05.009_bib0195","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4049\/jimmunol.84.4.384","article-title":"Studies on immunity to toxins of clostridium botulinum","volume":"84","author":"Wright","year":"1960","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2012.05.009_bib0200","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.90.5.697","article-title":"Studies on immunity to toxins of clostridium botulinum. Ix. Immunologic response of man to purified pentavalent abcde botulinum toxiod","volume":"90","author":"Fiock","year":"1963","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2012.05.009_bib0205_1","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/IAI.55.11.2541-2545.1987","article-title":"Immunization of mice against tetanus with fragments of tetanus toxin synthesized in escherichia coli","volume":"55","author":"Fairweather","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0210","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of clostridium botulinum neurotoxin serotype a expressed from a synthetic gene in escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0215_1","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/IAI.01025-07","article-title":"Subunit vaccine against the seven serotypes of botulism","volume":"76","author":"Baldwin","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0220","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0041-0101(98)00146-9","article-title":"Development of recombinant vaccines for botulinum neurotoxin","volume":"36","author":"Smith","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.mib.2012.05.009_bib0225_1","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type a binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0230","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/IAI.71.3.1147-1154.2003","article-title":"Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component","volume":"71","author":"Park","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0235","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes a and e","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the c-terminal part of the botulinum neurotoxin a is essential for the generation of protective antibodies","volume":"572","author":"Tavallaie","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mib.2012.05.009_bib0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/IAI.00843-07","article-title":"Recombinant holotoxoid vaccine against botulism","volume":"76","author":"Pier","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0250","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2009.05.030","article-title":"Production of catalytically inactive bont\/a1 holoprotein and comparison with bont\/a1 subunit vaccines against toxin subtypes a1, a2, and a3","volume":"27","author":"Webb","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.009_bib0255","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.imbio.2010.12.009","article-title":"Regions of botulinum neurotoxin a light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies","volume":"216","author":"Atassi","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.mib.2012.05.009_bib0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imbio.2011.08.009","article-title":"Molecular immune recognition of botulinum neurotoxin b. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire bont\/b molecule","volume":"217","author":"Atassi","year":"2012","journal-title":"Immunobiology"},{"issue":"Suppl. 1","key":"10.1016\/j.mib.2012.05.009_bib0265","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/(SICI)1099-1263(199912)19:1+<S35::AID-JAT612>3.0.CO;2-9","article-title":"Protection against botulinum toxins provided by passive immunization with botulinum human immune globulin: evaluation using an inhalation model","volume":"19","author":"Gelzleichter","year":"1999","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.mib.2012.05.009_bib0270","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1016\/j.vaccine.2010.08.076","article-title":"Botulinum neurotoxin neutralizing activity of immune globulin (ig) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rbv a\/b)","volume":"28","author":"Shearer","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.009_bib0275","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2012.05.009_bib0280","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/IAI.00405-09","article-title":"Antibody protection against botulinum neurotoxin intoxication in mice","volume":"77","author":"Cheng","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0285","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/IAI.01084-09","article-title":"Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents","volume":"78","author":"Sepulveda","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0290","doi-asserted-by":"crossref","first-page":"e29941","DOI":"10.1371\/journal.pone.0029941","article-title":"A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model","volume":"7","author":"Mukherjee","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mib.2012.05.009_bib0295","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among botulinum neurotoxin-producing clostridial strains","volume":"189","author":"Hill","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mib.2012.05.009_bib0300","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/AEM.00201-11","article-title":"Purification, modeling, and analysis of botulinum neurotoxin subtype a5 (bont\/a5) from clostridium botulinum strain a661222","volume":"77","author":"Jacobson","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.mib.2012.05.009_bib0305","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/AEM.03109-09","article-title":"Sequence diversity of genes encoding botulinum neurotoxin type f","volume":"76","author":"Raphael","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.mib.2012.05.009_bib0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.febslet.2010.11.045","article-title":"Botulinum neurotoxin subtype a2 enters neuronal cells faster than subtype a1","volume":"585","author":"Pier","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mib.2012.05.009_bib0315","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/bi801686b","article-title":"Catalytic properties of botulinum neurotoxin subtypes a3 and a4","volume":"48","author":"Henkel","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.mib.2012.05.009_bib0320","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2006.07.040","article-title":"A structural perspective of the sequence variability within botulinum neurotoxin subtypes a1-a4","volume":"362","author":"Arndt","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.mib.2012.05.009_bib0325_1","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1016\/j.vaccine.2011.07.134","article-title":"Subunit vaccine efficacy against botulinum neurotoxin subtypes","volume":"29","author":"Henkel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.009_bib0330","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/newbio235016a0","article-title":"Bacteriophage and the toxigenicity of clostridium botulinum type d","volume":"235","author":"Eklund","year":"1972","journal-title":"Nat New Biol"},{"key":"10.1016\/j.mib.2012.05.009_bib0335","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1126\/science.172.3982.480","article-title":"Bacteriophage and the toxigenicity of clostridium botulinum type c","volume":"172","author":"Eklund","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.mib.2012.05.009_bib0340","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/IAI.57.9.2886-2891.1989","article-title":"Molecular diversity of neurotoxins from clostridium botulinum type d strains","volume":"57","author":"Moriishi","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.009_bib0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0167-4781(96)00006-1","article-title":"Mosaic structures of neurotoxins produced from clostridium botulinum types c and d organisms","volume":"1307","author":"Moriishi","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mib.2012.05.009_bib0350_1","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant clostridium botulinum c1 and d binding domain subunit (hc) vaccines against c and d neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.009_bib0355_1","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1021\/bi100865f","article-title":"Identification of a unique ganglioside binding loop within botulinum neurotoxins c and d-sa","volume":"49","author":"Karalewitz","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.mib.2012.05.009_bib0360_1","doi-asserted-by":"crossref","first-page":"91ra62","DOI":"10.1126\/scitranslmed.3002234","article-title":"Rational design of a meningococcal antigen inducing broad protective immunity","volume":"3","author":"Scarselli","year":"2011","journal-title":"Sci Transl Med"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136952741200063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136952741200063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T22:48:13Z","timestamp":1743374893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S136952741200063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S136952741200063X"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2012.05.009","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}